Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Collaboration and other revenue	$ 11,000	$ 0
Operating expenses:
Research and development expense	63,095	103,731
General and administrative expense	21,848	25,956
Total operating expenses	84,943	129,687
Loss from operations	(73,943)	(129,687)
Other income
Interest income	3,369	6,312
Gain (loss) on warrant liability	807	0
Other income (expense)	(9)	(87)
Total other income	4,167	6,225
Net loss and comprehensive loss	$ (69,776)	$ (123,462)
Net loss per common share, basic	$ (1.44)	$ (2.58)
Net loss per common share, diluted	$ (1.44)	$ (2.58)
Weighted-average shares of common stock outstanding, basic	48,573,364	47,777,568
Weighted-average shares of common stock outstanding, diluted	48,573,364	47,777,568